Searched for
GREVLIMID IMPACT
Can US generics momentum and CDMO strength keep pharma earnings steady this quarter?Indian pharmaceutical companies are set for a steady September quarter. Growth in the US generics market and domestic sales will drive perf...13 Oct, 2025, 05.55 AM IST- Cipla Q1 results preview: Muted US sales to hit revenue YoY. 4 things to watch out forCipla's June quarter earnings are anticipated to reveal a mixed performance, with robust India sales partially offsetting challenges in the...24 Jul, 2025, 12.11 PM IST
- Banking and IT show muted growth, pharma thrives in March quarter resultsMarch quarter results reveal mixed performance across sectors. Banking and IT experienced muted profit growth, while pharma demonstrated st...29 May, 2025, 05.38 AM IST
- Stocks to buy today: MOSL upgrades Aurobindo Pharma to buy; Nuvama sees over 30% upside in DRLChoice Broking maintains a positive outlook on Mahindra & Mahindra (M&M), citing its dominant position in the SUV and tractor markets and r...12 May, 2025, 10.28 AM IST
- Capacity push and new drugs critical for Aurobindo's healthA delay in drug approvals in the US market remains a concern for Aurobindo. The company stated that eight ANDAs (abbreviated new drug appli...20 Mar, 2025, 06.00 AM IST
- Dr Reddy's Labs shares up 3% after Q2 results. What should investors do?Dr. Reddy's Labs reported a 15% decline in Q2 net profit, despite a 17% rise in revenue driven by global generics. While analysts acknowled...06 Nov, 2024, 09.51 AM IST
- Cipla Q2 results preview: 3-6% revenue uptick seen, net profit may rise by up to 5.7%Cipla is set to report a 3-6% revenue growth for the September quarter, as forecasted by four brokerages. The earnings for Q2FY25 will be a...28 Oct, 2024, 11.10 AM IST
- Zydus Lifesciences shares fall 6%, brokerages neutral on Sterling Biotech dealZydus Lifesciences Share Price: Zydus Lifesciences' shares fell 6% to Rs 1,109 after acquiring a 50% stake in Sterling Biotech for Rs 550 c...26 Aug, 2024, 10.55 AM IST
- Cipla Q1 results preview: PAT may grow 6.5-14% YoY, up to 10% growth seen in revenueCipla reported Q1FY25 net profit expected between Rs 1,061-1,135 crore, with YoY growth of 6.5%-14%. Revenue estimated at Rs 6,749-6,879 cr...25 Jul, 2024, 10.02 PM IST
- Dr Reddy's shares rise 4% on Q3 PAT jump but brokerages remain unmoved. Here's whyThe drug maker on Tuesday reported an 11% year-on-year (YoY) jump in net profit at Rs 1,379 crore for the quarter ended December 31, 2023, ...31 Jan, 2024, 12.30 PM IST
- Sun facing some clouds is still a buy for analystsShares declined nearly 2.5% in Monday's trading before recouping most of its losses. The stock eventually closed at ₹968.50, down 0.14% fro...30 May, 2023, 06.40 AM IST
- Hold Dr. Reddy's Laboratories, target price Rs 5100: Sharekhan by BNP ParibasDr. Reddy's Laboratories, incorporated in the year 1984, is a Large Cap company (having a market cap of Rs 73305.57 Crore) operating in Pha...19 May, 2023, 02.01 PM IST
- Dr Reddy's tumbles 7% post Q4 results! Here's what brokerages recommendDr Reddy's Laboratories reported an 890% YoY surge in March quarter profit at Rs 960.1 crore but shares tumbled nearly 7% to Rs 4,545 in Th...11 May, 2023, 11.25 AM IST
- Hot Stocks: Brokerages on TCS, Sun Pharma, HPCL, ONGC and Oil IndiaJPMorgan maintained an underweight rating on TCS with a target price of Rs 2700. TCS Q4 missed expectations across the board led by US weak...13 Apr, 2023, 10.04 AM IST
- Buy Sun Pharmaceutical Industries, target price Rs 1180: JM FinancialSun Pharmaceutical Industries Ltd., incorporated in the year 1993, is a Large Cap company (having a market cap of Rs 254653.42 Crore) opera...02 Nov, 2022, 10.47 AM IST
- Buy Dr. Reddy's Laboratories, target price Rs 7685: JM FinancialDr. Reddy's Laboratories Ltd., incorporated in the year 1984, is a Large Cap company (having a market cap of Rs 70323.83 Crore) operating i...24 Aug, 2022, 09.36 AM IST
- Buy Dr. Reddy's Laboratories, target price Rs 5600: Axis SecuritiesDr. Reddy's Laboratories Ltd., incorporated in the year 1984, is a Large Cap company (having a market cap of Rs 77528.53 Crore) operating i...01 Nov, 2021, 10.28 AM IST
Load More
